Cargando…
How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study
BACKGROUND: Cancer is a significant health concern and is China’s leading cause of mortality. Targeted therapies, such as trastuzumab and rituximab, have enhanced clinical treatment efficacy. However, their high costs burden patients and healthcare systems considerably. Patient demographic factors f...
Autores principales: | Shang, Linlin, Lin, Yingtao, Fang, Wenqing, Liu, Yanyan, Bao, Yuwen, Li, Xin, Zhang, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488736/ https://www.ncbi.nlm.nih.gov/pubmed/37692767 http://dx.doi.org/10.2147/RMHP.S420899 |
Ejemplares similares
-
Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study
por: Fang, Wenqing, et al.
Publicado: (2021) -
The use of trastuzumab affected by health insurance policy in Jiangsu Province of China
por: Xia, Yiqin, et al.
Publicado: (2021) -
Insurance Coverage Policies for Personalized Medicine
por: Hresko, Andrew, et al.
Publicado: (2012) -
Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer
por: Lu, Christine Y., et al.
Publicado: (2018) -
Factors Associated with National Health Insurance Coverage in Indonesia
por: Sukartini, Tintin, et al.
Publicado: (2022)